December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

33.78 -1.05 (-3.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 307,777
Open 34.87
Bid (Size) 32.75 (200)
Ask (Size) 40.93 (200)
Prev. Close 34.83
Today's Range 33.41 - 35.04
52wk Range 28.34 - 50.79
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
Collegium Pharmaceutical’s first quarter was marked by solid execution and positive market reaction, supported by robust growth in its ADHD and pain manageme... 
Via StockStory
Topics Earnings
News headline image
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi... 
Via StockStory
Topics Economy

Performance

YTD
-25.8%
-25.8%
1 Month
-3.3%
-3.3%
3 Month
-26.2%
-26.2%
6 Month
-26.5%
-26.5%
1 Year
+15.1%
+15.1%

More News

Read More
News headline image
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
Via StockStory
Collegium Pharmaceutical (NASDAQ:COLL) Surges on Q1 Earnings Beat as JORNAY PM Revenue Jumps 36% ↗
Via Chartmill
Topics Earnings
Collegium Pharmaceutical Inc (NASDAQ:COLL) Priced for a Value Rebound ↗
Via Chartmill
Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results
Via StockStory
News headline image
Collegium (COLL) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 CY2026 Expectations, Stock Soars
Via StockStory
News headline image
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical (COLL) Q1 Earnings Report Preview: What To Look For
Via StockStory
News headline image
1 Small-Cap Stock on Our Watchlist and 2 We Question
Via StockStory
News headline image
3 Reasons to Sell COLL and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
News headline image
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Via StockStory
News headline image
3 Cash-Producing Stocks Walking a Fine Line
Via StockStory
News headline image
1 Value Stock on Our Buy List and 2 Facing Headwinds
Via StockStory
Topics ETFs
News headline image
GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy Stocks World Trade
News headline image
2 Profitable Stocks to Consider Right Now and 1 We Question
Via StockStory
Topics Bonds
News headline image
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know
Via StockStory
Topics Economy Stocks

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 33.78
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 05/15/26 04:00 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.09B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.